International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Welcome from the President

Yusuke TanigawaraDear members,

I hope that you are continuing to stay safe and healthy during this difficult time. We have all had extremely unusual experiences and sudden changes in our daily life and working/studying circumstances due to the COVID-19 pandemic. At the same time, I sincerely thank all medical and laboratory professionals for their devoted efforts to fight the virus and care patients.

Even in this challenging situation, I am pleased to see our IATDMCT colleagues demonstrate their expertise to contribute to medical service and public health. For example, the Immunosuppressive Drugs Committee has published a timely article in our TDM journal to alert clinicians on potential drug interactions with experimental COVID-19 treatments in transplant recipients. As discipline of TDM and CT, every member can do something, even small thing to support people. Please use your knowledge, skills and accumulated experiences.

While it will be some time until the world returns to a more normal status, IATDMCT continues to support members. Although the Banff Congress this September was forced to cancel sadly due to the COVID-19 pandemic, I look forward to near future when we can meet together discussing science and exchanging activities.

“There is always light behind the clouds.” (Louisa May Alcott)

Yusuke Tanigawara
IATDMCT President
14 May 2020


Dear Colleagues,

It is my great honor to serve as the 15th President for the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for the term 2019-2021, following the excellent past Presidents

I am the first President elected from non-European and non-American members. I greatly appreciate the support from the IATDMCT membership worldwide. At the same time, you may recognize this is an important symbolic message that the IATDMCT has become a true international association.

The mission of the IATDMCT is the promotion and advancement of the discipline of therapeutic drug monitoring and clinical toxicology, through Integration, Innovation and Influence on clinical science and practice.

The core activities of the Association are Annual Congress and Scientific Committees. Currently, we have 10 Scientific Committees with a variety of fields and we are about to launch a new Scientific Committee on ‘TDM of Biologics’.

The Annual Congress is an important opportunity for members to update the latest scientific knowledge and exchange research outcome and experiences, together with renewing mutual friendship. The Congress 2020 will be held in Banff, Canada and the Congress 2021 will be in Rome, Italy. I very much look forward to meeting all of you at coming IATDMCT Congresses.

We have currently members from about 70 countries of 6 continents. The association has large diversity in membership. This diversity includes not only professional backgrounds but also different countries and cultures, but we all share a common goal. IATDMCT is offering educational activities for people who want to learn TDM and Clinical Toxicology. The Member Resources Area of the IATDMCT web page provides you a variety of repository information and learning materials. I hope this will provide useful educational contents.

‘Therapeutic Drug Monitoring’ is the official journal of our association. The Editorial team completed transition last year from former Editor-in-Chief Michael Oellerich to new Editor-in-Chief Uwe Christians. I sincerely thank Michael Oellerich for his outstanding service and great contribution to the Journal. We expect Uwe Christians and his team will continue to serve and improve our Journal in order to increase the impact and visibility of the TDM and Clinical Toxicology sciences.

I am pleased to work hard for the IATDMCT and members and I look forward to moving forward with all of you.

“We may be separated by geography but we are united by science.”

I look forward to meeting all of you at future IATDMCT Congresses.

Yusuke Tanigawara 
IATDMCT President, 2019-2021